annual net income:
$998.37M-$1.35B(-57.47%)Summary
- As of today (April 18, 2025), TAK annual net profit is $998.37 million, with the most recent change of -$1.35 billion (-57.47%) on March 31, 2024.
- During the last 3 years, TAK annual net income has fallen by -$2.55 billion (-71.85%).
- TAK annual net income is now -71.85% below its all-time high of $3.55 billion, reached on March 31, 2021.
Performance
TAK Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$155.96M-$463.73M(-74.83%)Summary
- As of today (April 18, 2025), TAK quarterly net profit is $155.96 million, with the most recent change of -$463.73 million (-74.83%) on December 1, 2024.
- Over the past year, TAK quarterly net income has dropped by -$463.73 million (-74.83%).
- TAK quarterly net income is now -91.62% below its all-time high of $1.86 billion, reached on March 31, 2021.
Performance
TAK quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
$1.37B-$560.04M(-29.07%)Summary
- As of today (April 18, 2025), TAK TTM net profit is $1.37 billion, with the most recent change of -$560.04 million (-29.07%) on December 1, 2024.
- Over the past year, TAK TTM net income has dropped by -$560.04 million (-29.07%).
- TAK TTM net income is now -69.09% below its all-time high of $4.42 billion, reached on September 30, 2021.
Performance
TAK TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
TAK Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -57.5% | -74.8% | -29.1% |
| 3 y3 years | -71.8% | -33.8% | -41.6% |
| 5 y5 years | -18.1% | -91.6% | -61.5% |
TAK Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -57.5% | at low | -81.5% | +146.9% | -41.6% | +40.3% |
| 5 y | 5-year | -71.8% | +145.3% | -91.6% | +146.9% | -69.1% | +229.4% |
| alltime | all time | -71.8% | +174.9% | -91.6% | +108.2% | -69.1% | +206.2% |
Takeda Pharmaceutical Company Limited Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $155.96M(-74.8%) | $1.37B(-29.1%) |
| Sep 2024 | - | $619.69M(+1.4%) | $1.93B(+97.7%) |
| Jun 2024 | - | $611.00M(-3104.7%) | $974.15M(-4.0%) |
| Mar 2024 | $998.37M(-57.5%) | -$20.33M(-102.8%) | $1.01B(-20.2%) |
| Dec 2023 | - | $716.00M(-315.3%) | $1.27B(-9.2%) |
| Sep 2023 | - | -$332.51M(-151.0%) | $1.40B(-35.8%) |
| Jun 2023 | - | $651.48M(+176.4%) | $2.18B(-6.8%) |
| Mar 2023 | $2.35B(+14.6%) | $235.71M(-72.1%) | $2.34B(+16.6%) |
| Dec 2022 | - | $844.99M(+89.1%) | $2.00B(+20.2%) |
| Sep 2022 | - | $446.94M(-44.9%) | $1.67B(+1.8%) |
| Jun 2022 | - | $810.45M(-929.0%) | $1.64B(-21.4%) |
| Mar 2022 | $2.05B(-42.2%) | -$97.77M(-119.2%) | $2.09B(-48.4%) |
| Dec 2021 | - | $508.19M(+21.7%) | $4.04B(-8.5%) |
| Sep 2021 | - | $417.60M(-66.8%) | $4.42B(+9.4%) |
| Jun 2021 | - | $1.26B(-32.4%) | $4.04B(+13.8%) |
| Mar 2021 | $3.55B(+771.4%) | $1.86B(+110.4%) | $3.55B(+108.2%) |
| Dec 2020 | - | $884.32M(+2224.8%) | $1.70B(+225.2%) |
| Sep 2020 | - | $38.04M(-95.0%) | $524.31M(-53.1%) |
| Jun 2020 | - | $766.76M(+4743.6%) | $1.12B(+169.5%) |
| Mar 2020 | $407.05M(-66.6%) | $15.83M(-105.3%) | $414.73M(+211.0%) |
| Dec 2019 | - | -$296.32M(-146.9%) | $133.36M(-82.6%) |
| Sep 2019 | - | $631.45M(+890.2%) | $764.66M(+34.7%) |
| Jun 2019 | - | $63.77M(-124.0%) | $567.68M(-53.5%) |
| Mar 2019 | $1.22B(-27.7%) | -$265.54M(-179.3%) | $1.22B(+23.6%) |
| Dec 2018 | - | $334.98M(-22.9%) | $988.47M(-21.3%) |
| Sep 2018 | - | $434.46M(-39.4%) | $1.26B(+16.9%) |
| Jun 2018 | - | $717.36M(-243.9%) | $1.07B(-35.3%) |
| Mar 2018 | $1.69B(+58.7%) | -$498.34M(-182.7%) | $1.66B(-3.0%) |
| Dec 2017 | - | $602.88M(+138.6%) | $1.71B(+15.0%) |
| Sep 2017 | - | $252.69M(-80.6%) | $1.49B(+0.7%) |
| Jun 2017 | - | $1.30B(-392.1%) | $1.48B(+34.8%) |
| Mar 2017 | $1.06B(+59.1%) | -$446.18M(-217.7%) | $1.10B(-12.4%) |
| Dec 2016 | - | $379.13M(+56.6%) | $1.25B(-8.0%) |
| Sep 2016 | - | $242.03M(-73.7%) | $1.36B(-0.1%) |
| Jun 2016 | - | $921.53M(-417.1%) | $1.36B(+111.7%) |
| Mar 2016 | $668.06M | -$290.57M(-159.6%) | $643.85M(-167.2%) |
| Dec 2015 | - | $487.84M(+100.0%) | -$958.34M(-25.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $243.92M(+20.4%) | -$1.29B(+2.0%) |
| Jun 2015 | - | $202.66M(-110.7%) | -$1.26B(+10.9%) |
| Mar 2015 | -$1.33B(-225.2%) | -$1.89B(-1282.3%) | -$1.14B(-328.1%) |
| Dec 2014 | - | $160.09M(-40.7%) | $497.98M(-43.5%) |
| Sep 2014 | - | $269.75M(-17.5%) | $880.89M(-15.6%) |
| Jun 2014 | - | $326.95M(-226.3%) | $1.04B(-3.4%) |
| Mar 2014 | $1.06B(-40.8%) | -$258.81M(-147.7%) | $1.08B(-25.2%) |
| Dec 2013 | - | $543.00M(+25.4%) | $1.44B(+27.0%) |
| Sep 2013 | - | $432.93M(+18.9%) | $1.14B(+2.1%) |
| Jun 2013 | - | $363.96M(+246.6%) | $1.11B(-39.5%) |
| Mar 2013 | $1.80B(+14.3%) | $105.01M(-55.4%) | $1.84B(+44.2%) |
| Dec 2012 | - | $235.50M(-42.5%) | $1.28B(-6.4%) |
| Sep 2012 | - | $409.84M(-62.5%) | $1.36B(-21.0%) |
| Jun 2012 | - | $1.09B(-337.4%) | $1.73B(+10.6%) |
| Mar 2012 | $1.57B(-45.4%) | -$460.05M(-242.7%) | $1.56B(-35.3%) |
| Dec 2011 | - | $322.37M(-58.3%) | $2.42B(-18.3%) |
| Sep 2011 | - | $772.91M(-16.6%) | $2.96B(-5.1%) |
| Jun 2011 | - | $926.65M(+135.4%) | $3.12B(+8.0%) |
| Mar 2011 | $2.88B(-10.3%) | $393.59M(-54.4%) | $2.89B(-1.1%) |
| Dec 2010 | - | $863.04M(-7.4%) | $2.92B(+3.2%) |
| Sep 2010 | - | $931.84M(+33.8%) | $2.83B(+4.0%) |
| Jun 2010 | - | $696.69M(+63.8%) | $2.72B(-14.4%) |
| Mar 2010 | $3.21B(+36.1%) | $425.27M(-45.0%) | $3.18B(-8.1%) |
| Dec 2009 | - | $773.75M(-6.1%) | $3.46B(-6.4%) |
| Sep 2009 | - | $824.17M(-28.7%) | $3.70B(+5.0%) |
| Jun 2009 | - | $1.16B(+64.2%) | $3.52B(+48.9%) |
| Mar 2009 | $2.36B(-24.4%) | $703.69M(-30.4%) | $2.36B(+42.4%) |
| Dec 2008 | - | $1.01B(+56.3%) | $1.66B(+156.3%) |
| Sep 2008 | - | $647.15M | $647.15M |
| Mar 2008 | $3.12B(+8.6%) | - | - |
| Mar 2007 | $2.87B(+3.7%) | - | - |
| Mar 2006 | $2.77B(+7.2%) | - | - |
| Mar 2005 | $2.59B(+2.1%) | - | - |
| Mar 2004 | $2.53B(+13.4%) | - | - |
| Mar 2003 | $2.23B(+18.3%) | - | - |
| Mar 2002 | $1.89B(+41.8%) | - | - |
| Mar 2001 | $1.33B(+23.4%) | - | - |
| Mar 2000 | $1.08B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual net profit?
- What is the all time high annual net income for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual net income year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly net profit?
- What is the all time high quarterly net income for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly net income year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM net profit?
- What is the all time high TTM net income for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM net income year-on-year change?
What is Takeda Pharmaceutical Company Limited annual net profit?
The current annual net income of TAK is $998.37M
What is the all time high annual net income for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual net profit is $3.55B
What is Takeda Pharmaceutical Company Limited annual net income year-on-year change?
Over the past year, TAK annual net profit has changed by -$1.35B (-57.47%)
What is Takeda Pharmaceutical Company Limited quarterly net profit?
The current quarterly net income of TAK is $155.96M
What is the all time high quarterly net income for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly net profit is $1.86B
What is Takeda Pharmaceutical Company Limited quarterly net income year-on-year change?
Over the past year, TAK quarterly net profit has changed by -$463.73M (-74.83%)
What is Takeda Pharmaceutical Company Limited TTM net profit?
The current TTM net income of TAK is $1.37B
What is the all time high TTM net income for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM net profit is $4.42B
What is Takeda Pharmaceutical Company Limited TTM net income year-on-year change?
Over the past year, TAK TTM net profit has changed by -$560.04M (-29.07%)